4
Views
0
CrossRef citations to date
0
Altmetric
CRITICAL CARE CLINICAL CONUNDRUMS

Critical care clinical conundrums

Pages 101-107 | Published online: 30 Dec 2011

References

  • Keatinge WR. Death in heat waves: simple preventive measures may help reduce mortality. BMJ 2003; 327: 5 12–3 .
  • Boyer L, Robitail S, Auquier P. Heat wave in France: how did the media treat the crisis? BMJ 2003; 327: 876.
  • Grogan H, Hopkins PM. Heat stroke: implications for critical care and anaesthesia. Brit J Anaesth 2002; 88: 700–7.
  • Dermatte JE, O'Mara K, Buesher J, et al. Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med 1998; 129: 173–81.
  • Hamdy RC. Heat stroke. South Med J 2002; 95: 7 9 1–2.
  • Scottish Intercollegiate Guidelines Network and British Thoracic Society British Guideline on the Management of Asthma. January 2003.
  • Soroksky A, Stay D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest 2003; 123: 1018–25.
  • Phipps P. Garrard CS. The pulmonary physician in critical care. 12: acute severe asthma in the intensive care unit. Thorax 2003; 58: 8 1–8.
  • Jones A, Rowe B, Peters J, et al. Cochrane Database of Systematic Reviews, The Cochrane Library Issue 4, 2001.
  • Lau TT, Zed PJ. Does ketamine have a role in managing severe exacerbation of asthma in adults? Pharmacotherapy 2001; 21: 1100–6.
  • Baigel G. Volatile agents to avoid ventilating asthmatics. Anaesth Intensive Care 2003; 31: 208–10.
  • Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368–77.
  • van den Berghe G, Wouters P. Weekes F, et al. Intensive insulin therapy in the critically ill patient. N Engl J Med 2001; 345: 1359–67.
  • Bernand GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709.
  • Angus DC. Daybreak panel discussion: increasing survival in the severe sepsis patient: applying evidence based medicine into your practice. Long-term outcomes of the severe sepsis patient treated with drotrecogin alfa (activated). Program and abstracts of the 32nd Critical Care Congress; 28 January-2 Feb-ruary 2003; San Antonio, Texas, USA.
  • Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocrtisone and fludricortisone on mortality in patients with septic shock. JAMA 2002; 288: 86 2–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.